» Articles » PMID: 38406536

Transcranial Doppler Ultrasound Velocities in a Population of Unstudied African Children with Sickle Cell Anemia

Abstract

The greatest burden of sickle cell anemia (SCA) globally occurs in sub-Saharan Africa, where significant morbidity and mortality occur secondary to SCA-induced vasculopathy and stroke. Transcranial Doppler ultrasound (TCD) can grade the severity of vasculopathy, with disease modifying therapy resulting in stroke reduction in high-risk children. However, TCD utilization for vasculopathy detection in African children with SCA remains understudied. The objective was to perform a prospective, observational study of TCD findings in a cohort of children with SCA from the Democratic Republic of the Congo, Zambia, and Malawi. A total of 770 children aged 2-17 years without prior stroke underwent screening TCD. A study was scored as low risk when the time-averaged maximum of the mean (TAMMX) in the middle cerebral artery or terminal internal carotid artery was <170 cm/s but >50 cm/s, conditional risk when 170-200 cm/s, and high risk when >200 cm/s. Low-risk studies were identified in 604 children (78%), conditional risk in 129 children (17%), and high risk in three children (0.4%). Additionally, 34 (4%) were scored as having an unknown risk study (TAMMX <50 cm/s). Over the course of 15 months of follow-up, 17 children (2.2%) developed new neurologic symptoms (six with low-risk studies, seven with conditional risk, and four with unknown risk). African children with SCA in this cohort had a low rate of high-risk TCD screening results, even in those who developed new neurologic symptoms. Stroke in this population may be multifactorial with vasculopathy representing only one determinant. The development of a sensitive stroke prediction bundle incorporating relevant elements may help to guide preventative therapies in high-risk children.

Citing Articles

Incident Stroke in Pediatric Sickle cell Anemia Despite Overall Improved Transcranial Doppler Velocity in a Ugandan Hydroxyurea Trial: Antecedent and ongoing risks.

Wambaka B, Mpungu A, Mboizi V, Kalibbala D, Nambatya G, Murungi S medRxiv. 2025; .

PMID: 39974085 PMC: 11838932. DOI: 10.1101/2025.01.28.25320389.


Transcranial Doppler ultrasound velocities in a population of unstudied African children with sickle cell anemia.

OBrien N, Moons P, Johnson H, Tshimanga T, Musungufu D, Ekandji R EJHaem. 2024; 5(1):3-10.

PMID: 38406536 PMC: 10887331. DOI: 10.1002/jha2.818.

References
1.
Prussien K, Salihu A, Abdullahi S, Galadanci N, Bulama K, Belonwu R . Associations of transcranial doppler velocity, age, and gender with cognitive function in children with sickle cell anemia in Nigeria. Child Neuropsychol. 2018; 25(6):705-720. PMC: 6545195. DOI: 10.1080/09297049.2018.1526272. View

2.
Adams R, Nichols 3rd F, Aaslid R, McKie V, McKie K, Carl E . Cerebral vessel stenosis in sickle cell disease: criteria for detection by transcranial Doppler. Am J Pediatr Hematol Oncol. 1990; 12(3):277-82. DOI: 10.1097/00043426-199023000-00005. View

3.
Adams R, Kutlar A, McKie V, Carl E, Nichols F, Liu J . Alpha thalassemia and stroke risk in sickle cell anemia. Am J Hematol. 1994; 45(4):279-82. DOI: 10.1002/ajh.2830450402. View

4.
Marks L, Munube D, Kasirye P, Mupere E, Jin Z, Larussa P . Stroke Prevalence in Children With Sickle Cell Disease in Sub-Saharan Africa: A Systematic Review and Meta-Analysis. Glob Pediatr Health. 2018; 5:2333794X18774970. PMC: 5954575. DOI: 10.1177/2333794X18774970. View

5.
Galadanci N, Abdullahi S, Vance L, Tabari A, Ali S, Belonwu R . Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial). Am J Hematol. 2018; 93(3):E83. DOI: 10.1002/ajh.25012. View